Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Ravindra D. Yeole"'
Publikováno v:
Journal of Analytical Science and Technology, Vol 11, Iss 1, Pp 1-9 (2020)
Abstract Alalevonadifloxacin mesylate (ALA), pro-drug of levonadifloxacin is a new antibiotic approved in India to treat infections caused by Gram-positive bacteria. Alkyl mesylates (AMs) are known genotoxic impurities (GTI’s) formed in drug substa
Externí odkaz:
https://doaj.org/article/3eb5d9728342463e962ab0b796486c24
Publikováno v:
Drug Analytical Research, Vol 2, Iss 1, Pp 36-45 (2018)
A high performance liquid chromatography (HPLC) method with tandem mass spectrometric detection (MS/MS) has been developed and validated for the simultaneous quantification of cefepime and tazobactam in dog plasma. The method was developed on amide c
Externí odkaz:
https://doaj.org/article/d1fdff84772d475c87dad6c07770a109
Autor:
Rajiv A. Jadhav, Vinod K. Ahirrao, Rushikesh H. Patil, Kiran B. More, Anil R. Tile, Vipul P. Rane, Pravin S. Sonawane, Ravindra D. Yeole
Publikováno v:
Analytical Chemistry Letters. 12:409-418
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::347b988b3bbb5f3eb284b7d4e41fd6ee
https://doi.org/10.1080/22297928.2022.2073261
https://doi.org/10.1080/22297928.2022.2073261
Autor:
Vipul P. Rane, Rushikesh H. Patil, Kiran R. Patil, Amin R. Pathan, Sukantakumar Naik, Vinod K. Ahirrao, Rajiv A. Jadhav, Ravindra D. Yeole
Publikováno v:
Chromatographia. 85:155-165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ffb83622dbb6ac43880c60d8adfb741
https://doi.org/10.1007/s10337-021-04122-y
https://doi.org/10.1007/s10337-021-04122-y
Autor:
Vinod K. Ahirrao, Rushikesh H. Patil, Vipul P. Rane, Kiran R. Patil, Ravindra D. Yeole, Amin R. Pathan
Publikováno v:
Chromatographia. 84:1121-1130
WCK 4086 is new antibacterial drug being developed to treat infections caused by Gram positive bacteria. This study describes development of mass spectrometry (MS) compatible reversed phase liquid chromatographic method for separation, identification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::949f6e62fabddf0c3fb3864f46be159d
https://doi.org/10.1007/s10337-021-04095-y
https://doi.org/10.1007/s10337-021-04095-y
Autor:
Ravindra D. Yeole, Rajesh Chavan, Sachin Bhagwat, Nilesh Chavan, Mahesh Patel, V. S. Zope, Kiran R. Patil
Publikováno v:
Xenobiotica. 51:251-261
Nafithromycin is a next generation lactone ketolide antibiotic slated to enter phase III clinical development in India for the treatment of CABP as a shorter 800 mg-OD X3 day therapeutic regimen. N...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b71f502b57d9f6f1908dde5676f5c2
https://doi.org/10.1080/00498254.2020.1839983
https://doi.org/10.1080/00498254.2020.1839983
Publikováno v:
Journal of Chromatographic Science. 58:951-960
Alalevonadifloxacin (ALA, formerly described as WCK 2349) is a novel antibacterial drug developed to treat infections caused by Gram-positive bacteria. The current study was aimed to identify and quantify impurities in ALA. Mass spectrometry (MS) com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af6d893f8679c8781d0d34bd127b277
https://doi.org/10.1093/chromsci/bmaa068
https://doi.org/10.1093/chromsci/bmaa068
Autor:
Vipul P. Rane, Rajiv A. Jadhav, Amin R. Pathan, Ravindra D. Yeole, Kiran R. Patil, Vinod K. Ahirrao
Publikováno v:
Chromatographia. 83:1095-1105
A mass spectrometer compatible, reverse-phase high-performance liquid chromatography method capable to resolve twenty-six impurities and degradation products (DPs) in Ertapenem (ERT) has been developed. Eight dimer impurities (m/z 951) and two dehydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ac76a3e39cd2bd849fa3f895981aaf3
https://doi.org/10.1007/s10337-020-03928-6
https://doi.org/10.1007/s10337-020-03928-6
Publikováno v:
Journal of Analytical Science and Technology, Vol 11, Iss 1, Pp 1-9 (2020)
Alalevonadifloxacin mesylate (ALA), pro-drug of levonadifloxacin is a new antibiotic approved in India to treat infections caused by Gram-positive bacteria. Alkyl mesylates (AMs) are known genotoxic impurities (GTI’s) formed in drug substances isol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6dcbb32baf8a7772b8ceca0ee79219b
http://link.springer.com/article/10.1186/s40543-020-00214-w
http://link.springer.com/article/10.1186/s40543-020-00214-w
Autor:
Rajesh Chavan, Mahesh Patel, Nilesh Chavan, V. S. Zope, Sachin Bhagwat, Javeed Shaikh, Kiran R. Patil, Ravindra D. Yeole
Publikováno v:
Xenobiotica. 50:1149-1157
WCK 771 (INN: levonadifloxacin) is a novel antibacterial agent belonging to benzoquinolizine subclass of fluoroquinolones which is under clinical development as a parenteral formulation and its pro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e90b5e7bcc0024c1d66223d77b1e46b
https://doi.org/10.1080/00498254.2020.1756007
https://doi.org/10.1080/00498254.2020.1756007